How a Simple Blood Draw & Multi-Omic Testing Can Optimize Cancer Treatment Strategies
Time: 11:05 am
day: Day Three Track A
Details:
- ddPCR™ testing drives progress in early cancer diagnosis, personalized therapy, and molecular residual disease detection
- Proteomic testing can identify a patient’s immune response to cancer; identifying those patients with an aggressive disease state that may benefit from enhanced surveillance, immunotherapy combinations or chemotherapy
